Surgical Innovations Group (LSE:SUN) 3-1 Month Momentum %: 5.26% (As of Sep. 11, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Surgical Innovations Group 3-1 Month Momentum %?

Surgical Innovations Group LSE:SUN 3-1 Month Momentum % is 5.26% as of Sep. 11, 2026. The stock has 2 warning signs investors should review. Among 848 Medical Devices & Instruments companies, Surgical Innovations Group ranks better than 62.38% on this metric.

3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-11), Surgical Innovations Group's 3-1 Month Momentum % is 5.26%.

The industry rank for Surgical Innovations Group's 3-1 Month Momentum % or its related term are showing as below:

LSE:SUN's 3-1 Month Momentum % is ranked better than
62.38% of 848 companies
in the Medical Devices & Instruments industry
Industry Median: 0.86 vs LSE:SUN: 5.26

Surgical Innovations Group  (LSE:SUN) 3-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Surgical Innovations Group 3-1 Month Momentum % Related Terms


LSE:SUN vs ABT, SYK, MDT: 3-1 Month Momentum % Comparison

For the Medical Devices subindustry, Surgical Innovations Group's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surgical Innovations Group 3-1 Month Momentum % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Surgical Innovations Group's 3-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Surgical Innovations Group's 3-1 Month Momentum % falls into.



Surgical Innovations Group  (LSE:SUN) 3-1 Month Momentum % Calculation

3-1 Month Momentum % is calculated as following:

3-1 Month Momentum %=( Price 1-month ago / Price 3-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 3-1 Month Momentum % →
What does a 3-1 Month Momentum % of 5.26% mean?
Surgical Innovations Group (LSE:SUN) has a 3-1 Month Momentum % of 5.26% as of Sep. 11, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Surgical Innovations Group and its competitors. According to the industry distribution chart, Surgical Innovations Group ranks #319 out of 848 companies in the Medical Devices & Instruments industry, placing it in the top 37.6%.
Is Surgical Innovations Group's 3-1 Month Momentum % too high?
Surgical Innovations Group's current 3-1 Month Momentum % is 5.26%. The Medical Devices & Instruments industry median 3-1 Month Momentum % is 0.86. Surgical Innovations Group's value of 5.26% is 511.6% above this industry median. Based on the distribution chart, Surgical Innovations Group ranks #319 out of 848 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does Surgical Innovations Group's 3-1 Month Momentum % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Surgical Innovations Group ranks #319 out of 848 companies for 3-1 Month Momentum %. This puts Surgical Innovations Group in the upper half of its industry. The industry median 3-1 Month Momentum % is 0.86. Surgical Innovations Group's value of 5.26% is 511.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
The median 3-1 Month Momentum % among Medical Devices & Instruments companies is 0.86, based on 848 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surgical Innovations Group's current 3-1 Month Momentum % of 5.26% is 511.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Surgical Innovations Group and its competitors. For the Medical Devices & Instruments industry, the median 3-1 Month Momentum % is 0.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgical Innovations Group's current 3-1 Month Momentum % is 5.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Innovations Group stock overvalued right now?
Surgical Innovations Group (LSE:SUN) has a current 3-1 Month Momentum % of 5.26%. The current 3-1 Month Momentum % is 5.26% and 511.6% above the Medical Devices & Instruments industry median of 0.86. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Surgical Innovations Group (LSE:SUN), the current 3-1 Month Momentum % is 5.26% as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Surgical Innovations Group Business Description

Address Clayton Wood House, 6 Clayton Wood Bank, Leeds, GBR, LS16 6QZ
Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery (SI Brand), along with its label products through original equipment manufacturer (OEM) relationships, including precision engineering markets (PE). The Company's operating segments are SI Brand, OEM, and Distribution. The majority of its revenue is generated from the SI Brand segment, which is involved in the research, development, manufacture, and distribution of SI-branded minimally invasive devices. Geographically, the group derives a majority of its revenue from the United Kingdom, followed by Europe, the United States, the Asia-Pacific region, and the Rest of the world.